Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates

Press/Media

Period	18 Dec 2023

Media coverage

Title	Theralink announces groundbreaking RPPA study by partner GMU - reveals novel therapy options for hard-to-treat breast cancer patients that could lead to significant improvements in response rates
Media name/outlet	BioSpace
Country/Territory	United States
Date	18/12/23
URL	https://www.biospace.com/article/releases/theralink-announces-groundbreaking-rppa-study-by-partner-gmu-reveals-novel-therapy-options-for-hard-to-treat-breast-cancer-patients-that-could-lead-to-significant-improvements-in-response-rates/?s=95
Persons	Emmanuel Petricoin